BCR and diffuse large B-cell lymphoma: The CD79B gene is frequently affected by recurrent splice site mutations in DLBCL that frequently lead to intron 4 retention with premature termination of CD79B translation, resulting in BCR overexpression and enhancement of NF-κB and AKT signaling [44].